The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...
More than a third of older Singaporean adults have undiagnosed age-related eye diseases, increasing visual impairment risk.
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback